Rb. Lydiard et al., CSF CHOLECYSTOKININ-OCTAPEPTIDE IN PATIENTS WITH BULIMIA-NERVOSA AND IN NORMAL COMPARISON SUBJECTS, The American journal of psychiatry, 150(7), 1993, pp. 1099-1101
Cholecystokinin octapeptide (CCK-8) appears to modulate appetitive beh
avior, and in rodents, anxiety-related behavior. The authors studied C
CK-8 in patients with bulimia nervosa. CSF concentrations of CCK-8 wer
e measured in 11 drug-free female patients with DSM-III-R-defined buli
mia nervosa and in 16 normal subjects. The bulimic patients had signif
icantly lower levels of CCK-8 than the comparison subjects. CCK-8 conc
entrations were inversely correlated with scores on the anger-hostilit
y, anxiety, and interpersonal sensitivity subscales of the SCL-90-R. T
hey were not significantly correlated with age, percentage of standard
ized average body weight, or mean weekly frequency of binge eating or
vomiting. The results indicate that central CCK-8 abnormalities may pl
ay a role in the pathophysiology of bulimia nervosa.